Lipoproteins are substrates for human secretory group IIA phospholipase A2: Preferential hydrolysis of acute phase HDL

Journal of Lipid Research

Volumn 39, Issue 11, 1998, Pages 2150-2160

  Pruzanski, Waldemar ^a   Stefanski, Eva ^a   De Beer, Frederick C ^c   De Beer, Maria C ^c   Vadas, Peter ^a   Ravandi, Amir ^b   Kuksis, Arnis ^b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Atherosclerosis; Free fatty acids; Group IIA phospholipase A2; Hydrolysis; Lipoproteins; Lysophosphatidylcholine

Indexed keywords

ALKENYL GROUP; ALKYL ETHER; ARACHIDONIC ACID; CHOLINE; FATTY ACID; HIGH DENSITY LIPOPROTEIN; LINOLENIC ACID; LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPASE A2; SERUM AMYLOID A; SPHINGOMYELIN;

ACUTE PHASE RESPONSE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BIOACCUMULATION; CHRONIC INFLAMMATION; CONCENTRATION RESPONSE; ENZYME ACTIVATION; ENZYME SPECIFICITY; ENZYME SUBSTRATE; HUMAN; HYDROLYSIS; ION PAIR CHROMATOGRAPHY; LIPID COMPOSITION; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REACTION TIME; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ACUTE-PHASE REACTION; ALDEHYDES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FATTY ACIDS, NONESTERIFIED; HUMANS; HYDROLYSIS; LIPID PEROXIDES; LIPOPROTEINS, HDL; MASS SPECTROMETRY; PHOSPHOLIPASES A; PHOSPHOLIPIDS; ULTRACENTRIFUGATION;

EID: 0031785119     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. 2 expression and inflammation: the relationship with associated disease states. J. Lipid Mediat. 8: 1-30.
2. 2 as an index of disease activity in rheumatoid arthritis. Prospective double blind study of 212 patients. J. Rheumatol. 23: 1162-1166.
3. 2 activity and antilipocortin antibodies in systemic lupus erythematosus. Correlative study with disease activity. J. Rheumatol. 21: 252-257.
4. 2: influence on lipoprotein metabolism. J. Lipid Res. 38: 2232-2239.
5. 2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells. FEBS Lett. 261: 171-174.
6. 2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins. Arterioscler. Thromb. Vasc. Biol. 17: 300-309.
7. 2 type II to proteoglycans. Differential effect of glycosaminoglycans on enzyme activity. J. Biol. Chem. 271: 26307-26314.
8. 2 isoforms in human normal and atherosclerotic arterial wall. Arterioscler. Thromb. Vasc. Biol. 17: 2257-2263.
9. 2 gene family in mammals. J. Biol. Chem. 272: 17247-17250.
10. Van Lenten, B. J., S. Y. Hama, F. C. de Beer, D. M. Stafforini, T. M. McIntyre, S. M. Prescott, B. N. La Du, A. M. Fogelman, and M. Navab. 1995. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell co-cultures. J. Clin. Invest. 96: 2758-2767.
11. Parthasarathy, S., J. Barnett, and L. C. Fong. 1990. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim. Biophys. Acta. 1044: 275-283.
12. Tall, A. R. 1990. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J. Clin. Invest. 86: 379-384.
13. Bamberger, M., S. Lund-Katz, M. C. Phillips, and G. H. Rothblat. 1985. Mechanism of the hepatic lipase induced accumulation of high-density lipoprotein cholesterol by cells in culture. Biochemistry. 24: 3693-3701.
14. 2. Biochem. J. 309: 461-464.
15. 2-modified LDL is taken up at enhanced rate by macrophages. Biochem. Biophys. Res. Commun. 185: 465-472.
16. 2-modified low density lipoprotein by human adipocytes. Biochem. Cell. Biol. 68: 1243-1249.
17. Coetzee, G. A., A. F. Strachan, D. R. van der Westhuyzen, H. C. Hoppe, M. S. Jeenah, and F. C. de Beer. 1986. Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. J. Biol. Chem. 261: 9644-9651.
18. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
19. Fenner, C., R. R. Trant, D. T. Mason, and J. W. Wikman-Coffelt. 1975. Quantification of Coomassie Blue-stained proteins in polyacrylamide gels based on analyses of eluted dye. Anal. Biochem. 63: 595-602.
20. Goldstein, J. L., S .K. Basu, and M. S. Brown. 1983. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Meth. Enzymol. 98: 241-260.
21. 2 from synovial fluid in rheumatoid arthritis. J. Biochem. 100: 1297-1303.
22. Folch, J., M. Lees, and G. H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipids from animal tissue. J. Biol. Chem. 226: 497-509.
23. Myher, J. J., A. Kuksis, and S. Pind. 1989. Molecular species of glycerophospholipids and sphingomyelins of human erythrocytes: improved method of analysis. Lipids. 24: 396-407.
24. Myher, J. J., A. Kuksis, and S. Pind. 1989. Molecular species of glycerophospholipids and sphingomyelins of human plasma: comparison to red blood cells. Lipids. 24: 408-418.
25. Myher, J. J., and A. Kuksis. 1984. Determination of plasma total lipid profiles by capillary gas-liquid chromatography. J. Biochem. Biophys. Methods. 10: 13-23.
26. Ravandi, A., A. Kuksis, J. J. Myher, and L. Marai. 1995. Determination of lipid ester ozonides and core aldehydes by high-performance liquid chromatography with on-line mass spectrometry. J. Biochem. Biophys. Methods. 30: 271-285.
27. 2 alters the expression of selected apoB-100 epitopes and the interaction of LDL with cells. J. Lipid Res. 28: 729-743.
28. Kisilevsky, R., and L. Subrahmanyan. 1992. Serum amyloid A changes high density lipoproteins cellular affinity. A clue to serum amyloid A's principal function. Lab. Invest. 66: 778-785.
29. de Beer, F. C., E. A. Fagan, G. R. V. Hughes, R. K. Mallya, J. G. Lanham, and M.B. Pepys. 1982. Serum amyloid-A-protein concentration in inflammatory diseases and its relationship t1o the incidence of reactive systemic amyloidosis. Lancet. 2: 231-234.
30. Meek, R. L., S. Urieli-Shoval, and E. P. Benditt. 1994. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: impliations for serum amyloid A function. Proc. Natl. Acad. Sci. USA. 91: 3186-3190.
31. 2 in human atherosclerotic plaques. Atherosclerosis. 118: 173-181.
32. Wolfe, F., D. Mitchell, J. T. Sibley, J. F. Fries, D. A. Bloch, C. A. Williams, P. W. Spitz, M. M. Hager, S. M. Kleinheksel, and M. A. Cathey. 1994. The mortality of rheumatoid arthritis. Arthritis Rheum. 37: 481-494.
33. Ip, J. H., V. Fuster, L. Badimon, J. Badimon, M. B. Taubman, and J. H. Chesebro. 1990. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J. Am. Coll. Cardiol. 15: 1667-1687.
34. 2 enzymes present in P388D1 macrophages. J. Biol. Chem. 271: 6758-6765.
35. 2. Crit. Rev. Immunol. 17: 225-283.
36. 2. Am. J. Pathol. 134: 807-811.
37. 2 induces an inflammatory response in rabbit joints. J. Immunol. 146: 3904-3910.
38. 2 in rabbits. J. Invest. Dermatol. 86: 380-383.
39. Kume, N., M. I. Cybulsky, and M. A. Gimbrone, Jr. 1992. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest. 90: 1138-1144.
40. Locher, R., B. Weisser, T. Mengden, C. Brunner, and W. Vetter. 1992. Lysolecithin actions on vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 183: 156-162.
41. Quinn, M. T., S. Parthasarathy, and D. Steinberg. 1988. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc. Natl. Acad. Sci. USA. 85: 2805-2809.
42. Yagi, K., S. Komura, H. Kojima, Q. Sun, N. Nagata, N. Ohishi, and M. Nishikimi. 1996. Expression of human phospholipid hydroperoxide glutathione peroxidase gene for protection of host cells from lipid hydroperoxide-mediated injury. Biochem. Biophys. Res. Commun. 219: 486-491.
43. Kaneko, T., N. Baba, and M. Matsuo. 1996. Cytotoxicity of phosphatidylcholine hydroperoxides is exerted through decomposition of fatty acid hydroperoxide moiety. Free Radical Biol. Med. 21: 173-179.
44. Brewer, H. B., Jr., and D. J. Racier. 1991. HDL: structure, function and metabolism. Prog, Lipid Res. 30: 139-144.
45. Witztum, J. L., and D. Steinberg. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88: 1785-1792.
46. Steinberg, D., S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witztum. 1989. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:915-924.
47. Steinberg, D., and J. L. Wiztum. 1990. Lipoproteins and atherogenesis. Current concepts. J. Am. Med. Assoc. 264: 3047-3052.
48. Berliner, J. A., and J. W. Heinecke. 1996. The role of oxidized lipoproteins in atherogenesis. Free Radical Biol. & Med. 30: 707-727.
49. Acton, S., A. Rigotti, K. T. Landschulz, S. Xu, H. H. Hobbs, and M. Krieger. 1996. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 271: 518-520.
50. Ji, Y., B. Jian, N. Wang, Y. Sun, M. L. Moya, M. C. Phillips, G. H. Rothblat, J. B. Swaney, and A. R. Tall. 1997. Scavenger receptor promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272: 20982-20985.
51. Rotondo, D. 1995. Fatty acid modulation of cell responsiveness. Biochem. Soc. Trans. 23: 191-196.